PL1754491T3 - Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego - Google Patents

Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego

Info

Publication number
PL1754491T3
PL1754491T3 PL05743236T PL05743236T PL1754491T3 PL 1754491 T3 PL1754491 T3 PL 1754491T3 PL 05743236 T PL05743236 T PL 05743236T PL 05743236 T PL05743236 T PL 05743236T PL 1754491 T3 PL1754491 T3 PL 1754491T3
Authority
PL
Poland
Prior art keywords
receptor agonist
muscarinic receptor
preparation containing
ophthalmic
absorption type
Prior art date
Application number
PL05743236T
Other languages
English (en)
Inventor
Akiharu Isowaki
Akira Ohtori
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of PL1754491T3 publication Critical patent/PL1754491T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
PL05743236T 2004-05-21 2005-05-20 Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego PL1754491T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004151248 2004-05-21
PCT/JP2005/009709 WO2005113002A1 (ja) 2004-05-21 2005-05-20 ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
EP05743236A EP1754491B1 (en) 2004-05-21 2005-05-20 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist

Publications (1)

Publication Number Publication Date
PL1754491T3 true PL1754491T3 (pl) 2010-08-31

Family

ID=35428256

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05743236T PL1754491T3 (pl) 2004-05-21 2005-05-20 Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego

Country Status (9)

Country Link
US (1) US20070053964A1 (pl)
EP (1) EP1754491B1 (pl)
JP (1) JP4308255B2 (pl)
CN (1) CN1819846A (pl)
AT (1) ATE459351T1 (pl)
DE (1) DE602005019724D1 (pl)
ES (1) ES2342085T3 (pl)
PL (1) PL1754491T3 (pl)
WO (1) WO2005113002A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070104912A (ko) * 2005-02-17 2007-10-29 센주 세이야꾸 가부시키가이샤 안과용 고형 외용약제
KR20090042956A (ko) * 2006-08-28 2009-05-04 센주 세이야꾸 가부시키가이샤 안과 경피 흡수형 제제
JP4746714B2 (ja) * 2008-05-16 2011-08-10 Ａｘｉｓ株式会社 線維筋痛症治療用医薬組成物
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
RS59483B1 (sr) * 2009-10-30 2019-12-31 Intratus Inc Postupci i kompozicije za neprekidno oslobađanje lekova
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN102846607A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以盐酸西维美林为活性成分的固体制剂及其应用
AR104177A1 (es) * 2015-04-03 2017-07-05 Santen Pharmaceutical Co Ltd Sistema para la administración de fármacos en la glándula lagrimal
TW201705956A (zh) * 2015-05-12 2017-02-16 參天製藥股份有限公司 唑系抗真菌藥之對眼瞼皮膚的投與
LT3681500T (lt) 2018-04-24 2022-06-27 Allergan, Inc. Pilokarpino hidrochlorido naudojimas presbiopijos gydymui
WO2020072971A1 (en) * 2018-10-06 2020-04-09 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use
TWI809317B (zh) * 2020-09-29 2023-07-21 美商百歐賽那生技公司 蕈毒鹼性促效劑眼用製劑及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
EP1221315A4 (en) * 1999-10-13 2007-12-12 Senju Pharma Co ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING
JP3677421B2 (ja) * 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
EP1644320B1 (en) * 2003-07-03 2008-01-16 Eli Lilly And Company Indane derivates as muscarinic receptor agonists

Also Published As

Publication number Publication date
WO2005113002A1 (ja) 2005-12-01
EP1754491A4 (en) 2008-09-03
EP1754491B1 (en) 2010-03-03
EP1754491A1 (en) 2007-02-21
ES2342085T3 (es) 2010-07-01
JP4308255B2 (ja) 2009-08-05
ATE459351T1 (de) 2010-03-15
US20070053964A1 (en) 2007-03-08
JPWO2005113002A1 (ja) 2008-03-27
DE602005019724D1 (de) 2010-04-15
CN1819846A (zh) 2006-08-16

Similar Documents

Publication Publication Date Title
PL1754491T3 (pl) Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego
PE20081441A1 (es) Subtipo de amidas selectivas de diazabicicloalcanos
BRPI0518793A2 (pt) mÉtodos para tratar, controlar ou prevenir uma doenÇa ou distérbio de imunodeficiÊncia, e para melhorar a resposta imune a um imunogene, e, composiÇço farmacÊutica
WO2005079851A3 (en) Dopamine-agonist combination therapy with sedatives for improving sleep quality
IN2013MN01699A (pl)
AU2003257588A1 (en) REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
NO20060612L (no) Spiro [1-azabicyklo[2.2.2]-oktan-3,5'-oksazolidin]-2'-on-derivater med affinitet til alfa-7-nikotin-acetylcholin reseptoren
ES2144980T1 (es) Metodos y composiciones para tratar la rinitis alergica y otros trastornos, empleando descarboetoxiloratadina.
WO2008108286A1 (ja) 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
EP2422798A3 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
IL179599A0 (en) Glucagon receptor antagonists, preparation and therapeutic uses
IL186355A (en) Asnapine malt crystalline show, a method for making it, pharmacological preparations containing it, its uses for preparing pharmaceutical formulations for the treatment of mental disorders such as schizophrenia or bipolar disorder and its microcrystals
EP1749517B8 (en) Stable pharmaceutical composition comprising linezolid form IV
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MX2007004976A (es) Antagonistas de receptor m1 y/o m3 en combinacion con otros compuestos activos para tratar trastornos respiratorios.
RU2010148787A (ru) Чрескожно абсорбируемый препарат
WO2008014256A3 (en) Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers
DE60043017D1 (de) Zusammensetzung für perkutane Absorption mit einem melantoninrezeptor-agonistisch wirkendem Wirkstoff
ES2193751T3 (es) Delta3-piperidinas triciclicas como antagonistas alfa2.
ATE555117T1 (de) Therapeutisches mittel gegen diabetisches makulaödem
WO2004096141A3 (en) Method for promoting uninterrupted sleep by administration of trospium chloride
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
JP6566707B2 (ja) 経皮唾液腺投与用の唾液分泌促進剤
WO2006034510A3 (en) Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
WO2004108077A3 (en) Method of mitigating the adverse effects of il-2